Prasun Mishra, M.Sc., Ph.D.
Prasun Mishra PhD is a scientist at Genentech, where his research is primarily focused on developing ‘lifesaving’ next-generation personalized anti-cancer drugs. He has over 15 years of experience in managing multidisciplinary translational research teams with a successful track record of driving drugs/ drug-combinations from research through clinical development. The significance of his research has been recognized in numerous awards, honors and lectureships, including prestigious NIH Earl Stadtman Lectureships, Thompson Reuters Lectureship, Federal Technology Transfer Awards and NCI Director’s Innovation Awards. Discoveries lead by him and his teams have contributed to the development of new and viable strategies of prevention, diagnosis and treatment of cancer patients in the clinic. He earned his PhD degree in Pharmacology from Rutgers University, NJ and a postdoctoral fellowship from National Institutes of Health (NIH), Bethesda, MD. Before moving to Genentech he served as a principal investigator at National Cancer Institute (NCI) on two peer-reviewed NCI/NIH-funded grants focused on developing improved anti-cancer therapy. He was also a part of NIH Entrepreneur and Commercialization Club, where he analyzed commercial and technical potential of early-stage technologies coming out of NIH. He has also served as a non-dilutive funding adviser to accelerate commercialization and helped organizations to compete for over $30 billion available funds in non-dilutive federal R&D funding. Moreover, his passion for translational research has resulted in over 100 presentations/publications including 5 US patents, 5 federal technology transfer awards and 7 drugs/drug combinations in clinical trials.